
1. br j clin pharmacol. 2015 feb;79(2):182-94. doi: 10.1111/bcp.12403.

the evolution three decades antiretroviral therapy: challenges, triumphs
and promise future.

tseng a(1), seet j, phillips ej.

author information: 
(1)university health network, toronto, ontario, canada; leslie dan faculty of
pharmacy, university toronto, toronto, ontario, canada.

the evolution human immunodeficiency virus (hiv) treatment improved our
understanding management complex pharmacological issues driven
improved outcomes quality life hiv-infected patient. issues
include adherence, long- short-term toxicities, pharmacoenhancement,
pharmacogenomics, therapeutic drug monitoring, differential penetration drugs 
into sanctuary sites, central nervous system, genital tract small
bowel, drug-drug drug-food interactions related cytochrome p450
drug-metabolizing enzymes, uridine diphosphate glucuronyltransferases drug
transporters, name few. future promise, increased
understanding immunopathogenesis hiv global public health
initiatives driving novel treatment approaches goals prevent, control
and, ultimately, eradicate hiv.

Â© 2014 british pharmacological society.

doi: 10.1111/bcp.12403 
pmcid: pmc4309625
pmid: 24730660  [indexed medline]

